STAAR Ovarian Cancer Foundation was honored Dec. 1 with an Inspirational Collaboration Award during the third annual World Ovarian Cancer Coalition Impact Awards.
The award celebrates the achievements of organizations that worked in partnership to make a difference in ovarian cancer. STAAR was recognized for its work in two collaborations that brought low-grade serous ovarian cancer into “sharp focus,” said Tristan Bilash, patient advocate and advisor to the World Ovarian Cancer Coalition, who presented the award.
“The first was a multi-stakeholder global survey of those living with a diagnosis of this type, aimed at better understanding the people and circumstances behind the diagnosis. The second major collaboration brought the patient voice to a United States Food and Drug Administration meeting they arranged, and where they met with U.S. officials, researchers, drug companies, and industry. This meeting was the first externally led patient-focused drug development meeting for any type of ovarian cancer, which has the potential of changing the future of drug development and approvals for this disease,” Bilash said.
Nicole Andrews, Chair of STAAR Ovarian Cancer Foundation, said: “Working in a rare cancer space with little funding, patients spread across the globe, and fewer researchers has allowed our board to understand the importance of collaboration for higher impact. This year‘s work helping low-grade serous cancer patients have their voices heard through the international patient needs survey and the Voices of LGSOC event would not have been possible without our global collaboration partners with whom we share this award: Cure Our Ovarian Cancer, World Ovarian Cancer Coalition, and Drs. Gershenson, Sun, Gourley, Grisham, Banerjee, Curry and deFazio—and of course Verastem Oncology, who generously sponsored these projects. Thank you to the World Ovarian Cancer Coalition for their invaluable contributions in promoting global collaborations.”
Clara MacKay, CEO of the World Ovarian Cancer Coalition said: “With cases set to rise by almost 42% by 2040, the work of advocates who work on behalf of all of those impacted by ovarian cancer is more important than ever. It is truly humbling to see such incredible work achieved over the last year by all of our winners, nominees, and the wider ovarian cancer community.”
About the World Ovarian Cancer Coalition
The World Ovarian Cancer Coalition is a not-for-profit organization, formally established in 2016, working across the globe towards a world where everyone with ovarian cancer has the best chance of survival, and the best quality of life—wherever they may live. More information can be found on www.worldovariancancercoalition.org
About STAAR Ovarian Cancer Foundation
STAAR Ovarian Cancer Foundation is the only nonprofit in the United States dedicated to low-grade serous ovarian cancer. It was co-founded by three women with LGSOC in early 2020. The foundation works with the global charity Cure Our Ovarian Cancer to advance research opportunities in the United States to find better treatment options for LGSOC.
For more information contact:
Director of Communications and Marketing
World Ovarian Cancer Coalition
STAAR Ovarian Cancer Foundation
World Ovarian Cancer Coalition Impact Awards